[Standards, options and recommendations for nutritional support in bone marrow transplant patients]
- PMID: 12016039
[Standards, options and recommendations for nutritional support in bone marrow transplant patients]
Abstract
Context: The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of French Cancer Centers (FNCLCC), the 20 French cancer centers and specialists from French public university and general hospitals and private clinics. Its main objective is the development of clinical practice guidelines to improve the quality of health care and outcome for cancer patients. The methodology is based on literature review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery.
Objectives: To develop, according to the definitions of the Standards, Options and Recommendations, clinical practice guidelines for nutritional support in bone marrow transplant patients.
Methods: Data were identified by searching Medline , web sites and the personal reference lists of members of the expert groups, then submitted for review to 75 independent reviewers.
Results: The main recommendations for nutritional support in bone marrow transplant patients are: 1) Nutritional evaluation and monitoring may be proposed to bone-marrow transplant recipients (options). 2) Nutritional evaluation consists of body weight assessment and percent weight loss evaluation (standard, expert agreement). 3) Nutritional monitoring should include daily weight monitoring, clinical monitoring of hydration and assessment of daily dietary intake (standard, expert agreement). 4) Artificial nutrition is recommended in immuno-suppressed bone marrow transplant patients. This is not systematically indicated in other situation (standard). 5) Artificial nutrition, intravenous hydration and oral nutrition can be proposed to bone-marrow transplant recipients (option). 6) There is no standard modality for artificial nutrition (level of evidence B 1). Exclusive enteral or parenteral nutrition and enteral plus parenteral nutrition may be proposed to bone-marrow transplant patients (options). 7) Lipid intake representing up to 30% of the non-protein caloric intake should be supplied to patients undergoing bone marrow transplantation (standard, level of evidence B1). 8) Oral supplementation with nitrogen substrates or glutamine is not recommended. Parenteral glutamine supplementation may be proposed (option).
Similar articles
-
[Standards, Options and Recommendations for home parenteral or enteral nutrition in adult cancer patients].Bull Cancer. 2001 Jun;88(6):605-18. Bull Cancer. 2001. PMID: 11459708 French.
-
[Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer].Bull Cancer. 2001 Oct;88(10):985-1006. Bull Cancer. 2001. PMID: 11713035 Review. French.
-
[Good clinical practice in nutritional management of head and neck cancer patients].Bull Cancer. 1999 Oct;86(10):843-54. Bull Cancer. 1999. PMID: 10572235 French.
-
[Good clinical practice in nutritional management in cancer patients: malnutrition and nutritional assessment].Bull Cancer. 1999 Dec;86(12):997-1016. Bull Cancer. 1999. PMID: 10660694 French.
-
[Standards, options and recommendations for tumor markers in colorectal cancer].Bull Cancer. 2001 Dec;88(12):1177-206. Bull Cancer. 2001. PMID: 11792611 Review. French.
Cited by
-
Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents.Einstein (Sao Paulo). 2021 Dec 10;19:eAE5254. doi: 10.31744/einstein_journal/2021AE5254. eCollection 2021. Einstein (Sao Paulo). 2021. PMID: 34909973 Free PMC article.
-
Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002).Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S101-6. doi: 10.1038/sj.bjc.6601091. Br J Cancer. 2003. PMID: 12915910 Free PMC article. No abstract available.
-
Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study).Trials. 2015 Apr 7;16:136. doi: 10.1186/s13063-015-0663-8. Trials. 2015. PMID: 25872934 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical